New recommendations address GLP-1 medications across women's reproductive years. As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to address one of medicine's most pressing unanswered questions: How should these medications be used by women before, during and after pregnancy?
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to address one of medicine's most pressing unanswered questions: How should these medications be used by women before, during and after pregnancy?
- Ponto de atenção: recommendations.
- Ponto de atenção: address.
- Ponto de atenção: medications.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Saúde.
